A - Z index - P

The section presents an alphabetical listing of all pages of the website. Choose a letter from the links below to view all pages with titles that start with that letter. Alternatively view the sitemap, which lists all pages by their topic and placement in the navigation.

• Pacemaker technical notes

• Packaging for medicines

• Packaging for medicines: Frequently asked questions

• Packaging for medicines: Legislation and guidelines

• Paediatric information: Requirements for submitting

• Paediatric medicines

• Paediatric Medicines Expert Advisory Group of the Commission on Human Medicines

• Paediatric Medicines Working Group of the Committee of the Safety of Medicines

• Paediatric Medicines Working Group of the Committee on Safety of Medicines: Minutes

• Paediatrics

• Paracetamol overdose

• Parallel import licences

• Parallel import licences: lists of granted licences

• Parallel imports (devices)

• Paramedics: exemptions from Medicines Act Restrictions

• Paroxetine overdose

• PARs for medicines

• Pathology - a one-stop resource for pathologists

• Patient and Public Engagement Expert Advisory Group of the Commission on Human Medicines

• Patient Group Directions in the NHS

• Patient Group Directions in the private, prison and police sectors

• Patient information leaflet (PIL) of the month

• Patient information leaflets

• Patient information leaflets: Applications for assessment

• Patient information leaflets: Frequently asked questions

• Patient information leaflets: Legislation and guidelines

• Patient Information Quality Unit (PIQU) performance figures

• Patient Information Working Group of Committee on Safety of Medicines

• Patient Information Working Group of the Committee on Safety of Medicines: Minutes

• Patient Reporting of Adverse Drug Reactions Working Group of the Committee on Safety of Medicines

• Patient Reporting of Adverse Drug Reactions Working Group of the Committee on Safety of Medicines: Minutes

• Patients and public: A one-stop resource

• Patients and public: Buying medicines online and counterfeit medicines

• Patients and public: Contacting the MHRA

• Patients and public: Herbal and homeopathic medicines

• Patients and public: Medicines and your family

• Patients and public: Medicines, devices and conditions

• Patients and public: News and hot topics

• Patients and public: Reporting safety problems

• Pelvic organ prolapse

• Pendant supplies

• Periodic fees

• Periodic Safety Update Reports

• Periodic Safety Update Reports: Medicines

• PET trials: Additional information

• PET trials: General information

• Peter Commins, Finance and Operations Director

• Pharmaceutical industry: A one-stop resource

• Pharmaceutical industry: Applying for a marketing authorisation

• Pharmaceutical industry: Clinical trials

• Pharmaceutical industry: Contacting the MHRA

• Pharmaceutical industry: Fees

• Pharmaceutical industry: Herbal, homeopathic and borderline medicines

• Pharmaceutical industry: Inspection

• Pharmaceutical industry: Legislation, guidance and policy

• Pharmaceutical industry: Manufacturing and wholesaling

• Pharmaceutical industry: News and hot topics

• Pharmaceutical industry: Post marketing authorisation approval

• Pharmaceutical industry: Product information and advertising

• Pharmaceutical industry: Safety and pharmacovigilance

• Pharmacist independent prescribing

• Pharmacovigilance - how we monitor the safety of medicines

• Pharmacovigilance Expert Advisory Group of the Commission on Human Medicines

• Pharmacovigilance inspection metrics

• Pharmacovigilance learning module

• Pharmacovigilance learning module (for reference only)

• Pharmacovigilance learning module: Adverse drug reactions

• Pharmacovigilance learning module: Filling out a Yellow Card

• Pharmacovigilance learning module: Further reading

• Pharmacovigilance learning module: Glossary

• Pharmacovigilance learning module: How is the potential new effect assessed?

• Pharmacovigilance learning module: How to report a suspected adverse drug reaction

• Pharmacovigilance learning module: Importance of monitoring adverse effects

• Pharmacovigilance learning module: Information sources on adverse drug reactions

• Pharmacovigilance learning module: Introduction

• Pharmacovigilance learning module: Pharmacovigilance

• Pharmacovigilance learning module: Sources for detailed information on adverse reactions

• Pharmacovigilance learning module: Sources for emerging information

• Pharmacovigilance learning module: Sources for use in the clinic

• Pharmacovigilance learning module: Test yourself

• Pharmacovigilance learning module: What happens to your Yellow Card submission?

• Pharmacovigilance learning module: What is the Yellow Card Scheme?

• Pharmacovigilance learning module: What should trigger reporting?

• Pharmacovigilance learning module: Who is responsible for pharmacovigilance?

• Pharmacovigilance legislation

• Pharmacovigilance Service Team

• Pharmacovigilance subcommittee Committee on Safety of Medicines

• Pharmacy - a one-stop resource for pharmacists

• Phase 1 Accreditation Scheme

• Phase I Accreditation Scheme

• Photo and image library

• Phthalates/DEHP in PVC medical devices

• Physiotherapy and occupational therapy - a one-stop resource

• Pioglitazone

• Points to consider when assessing causality

• Policy development and delivery

• Policy enquiries

• Poly Implant Prosthèse (PIP) breast implants

• Poly Implant Prosthèse (PIP) breast implants

• POP

• Portal

• Posters and leaflets

• Prescribing of medicines

• Press enquiries

• Press releases

• Press releases and statements relating to PIP implants

• Product safety: How we monitor

• Product-specific information and advice

• Product-specific information and advice A - F

• Product-specific information and advice G - L

• Product-specific information and advice M - Z

• Professional Skills for Government (PSG)

• Professor Angus Mackay OBE

• Professor Barrington Furr OBE

• Professor Sir Kent Woods, Chief Executive

• Professor Vincent Lawton CBE

• Prohibited or restricted herbal ingredients

• Project to consolidate and review UK medicines legislation

• Prosecutions (medicines)

• Prostheses: Manufacturers

• Protecting patient confidentiality

• Provisions to which the marketing authorisation is granted

• PSURs (Periodic Safety Update Reports)

• Public Assessment Reports (PARs)

• Public Assessment Reports for homeopathic medicines

• Public Assessment Reports for medicines

• Publication Scheme information guide

• Publication Scheme of Advisory Board on the Registration of Homoeopathic Products

• Publications

• Publications and consultations

• Publications for consumers

• PVC medical devices: presence of phthalates/DEHP